中国处方药
中國處方藥
중국처방약
CHINA PRESCRIPTION DRUG
2014年
10期
6-7
,共2页
朱菁锋%张健生%薛光华%张家济%李天保
硃菁鋒%張健生%薛光華%張傢濟%李天保
주정봉%장건생%설광화%장가제%리천보
皮质下动脉硬化性脑病%hs-CRP%临床价值
皮質下動脈硬化性腦病%hs-CRP%臨床價值
피질하동맥경화성뇌병%hs-CRP%림상개치
Subcortical arteriosclerotic encephalopathy%hs-CRP%Clinical value
目的:分析皮质下动脉硬化性脑病(SAE)患者血清hs-CRP测定的临床价值。方法SAE患者90例为观察组,同期健康志愿者90例作为对照组,对比两组血清hs-CRP水平;患者按病情程度分为轻、中、重,对比观察各组间hs-CRP水平。结果观察组平均血清hs-CRP水平显著高于对照组,不同程度病情间的hs-CRP水平亦有明显差异,程度越严重指标水平越高,差异均有统计学意义(P<0.05)。结论SAE患者血清hs-CRP水平相比正常人明显升高,且随着病情发展程度而逐渐升高,与病情之间有着密切的关系。
目的:分析皮質下動脈硬化性腦病(SAE)患者血清hs-CRP測定的臨床價值。方法SAE患者90例為觀察組,同期健康誌願者90例作為對照組,對比兩組血清hs-CRP水平;患者按病情程度分為輕、中、重,對比觀察各組間hs-CRP水平。結果觀察組平均血清hs-CRP水平顯著高于對照組,不同程度病情間的hs-CRP水平亦有明顯差異,程度越嚴重指標水平越高,差異均有統計學意義(P<0.05)。結論SAE患者血清hs-CRP水平相比正常人明顯升高,且隨著病情髮展程度而逐漸升高,與病情之間有著密切的關繫。
목적:분석피질하동맥경화성뇌병(SAE)환자혈청hs-CRP측정적림상개치。방법SAE환자90례위관찰조,동기건강지원자90례작위대조조,대비량조혈청hs-CRP수평;환자안병정정도분위경、중、중,대비관찰각조간hs-CRP수평。결과관찰조평균혈청hs-CRP수평현저고우대조조,불동정도병정간적hs-CRP수평역유명현차이,정도월엄중지표수평월고,차이균유통계학의의(P<0.05)。결론SAE환자혈청hs-CRP수평상비정상인명현승고,차수착병정발전정도이축점승고,여병정지간유착밀절적관계。
Objective To study sigificance of CRP level in patients with subcortical arteriosclerotic encephalopathy(SAE). Methods 90 SAE patients and 90 health cases were included. Patients were divided into three subgroups:mild group,moderate group and severe group. Hs-CRP level was compared among these three subgroups. Results The serum hs-CRP level in SAE group were higher than it in the control group(P<0.05). The significant difference were showed in different SAE subgroups(P < 0.05). Conclusion The serum level of hs-CRP was significantly higher in patients with SAE and was associated with disease severity .